Cargando…
TINF2 is a haploinsufficient tumor suppressor that limits telomere length
Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that tr...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707837/ https://www.ncbi.nlm.nih.gov/pubmed/33258446 http://dx.doi.org/10.7554/eLife.61235 |
_version_ | 1783617440814465024 |
---|---|
author | Schmutz, Isabelle Mensenkamp, Arjen R Takai, Kaori K Haadsma, Maaike Spruijt, Liesbeth de Voer, Richarda M Choo, Seunga Sara Lorbeer, Franziska K van Grinsven, Emma J Hockemeyer, Dirk Jongmans, Marjolijn CJ de Lange, Titia |
author_facet | Schmutz, Isabelle Mensenkamp, Arjen R Takai, Kaori K Haadsma, Maaike Spruijt, Liesbeth de Voer, Richarda M Choo, Seunga Sara Lorbeer, Franziska K van Grinsven, Emma J Hockemeyer, Dirk Jongmans, Marjolijn CJ de Lange, Titia |
author_sort | Schmutz, Isabelle |
collection | PubMed |
description | Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that truncate TIN2, a shelterin subunit that controls telomere length. Patient lymphocyte telomeres were unusually long. We show that the truncated TIN2 proteins do not localize to telomeres, suggesting that the mutations create loss-of-function alleles. Heterozygous knock-in of the mutations or deletion of one copy of TINF2 resulted in excessive telomere elongation in clonal lines, indicating that TINF2 is haploinsufficient for telomere length control. In contrast, telomere protection and genome stability were maintained in all heterozygous clones. The data establish that the TINF2 truncations predispose to a tumor syndrome. We conclude that TINF2 acts as a haploinsufficient tumor suppressor that limits telomere length to ensure a timely Hayflick limit. |
format | Online Article Text |
id | pubmed-7707837 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-77078372020-12-02 TINF2 is a haploinsufficient tumor suppressor that limits telomere length Schmutz, Isabelle Mensenkamp, Arjen R Takai, Kaori K Haadsma, Maaike Spruijt, Liesbeth de Voer, Richarda M Choo, Seunga Sara Lorbeer, Franziska K van Grinsven, Emma J Hockemeyer, Dirk Jongmans, Marjolijn CJ de Lange, Titia eLife Cancer Biology Telomere shortening is a presumed tumor suppressor pathway that imposes a proliferative barrier (the Hayflick limit) during tumorigenesis. This model predicts that excessively long somatic telomeres predispose to cancer. Here, we describe cancer-prone families with two unique TINF2 mutations that truncate TIN2, a shelterin subunit that controls telomere length. Patient lymphocyte telomeres were unusually long. We show that the truncated TIN2 proteins do not localize to telomeres, suggesting that the mutations create loss-of-function alleles. Heterozygous knock-in of the mutations or deletion of one copy of TINF2 resulted in excessive telomere elongation in clonal lines, indicating that TINF2 is haploinsufficient for telomere length control. In contrast, telomere protection and genome stability were maintained in all heterozygous clones. The data establish that the TINF2 truncations predispose to a tumor syndrome. We conclude that TINF2 acts as a haploinsufficient tumor suppressor that limits telomere length to ensure a timely Hayflick limit. eLife Sciences Publications, Ltd 2020-12-01 /pmc/articles/PMC7707837/ /pubmed/33258446 http://dx.doi.org/10.7554/eLife.61235 Text en © 2020, Schmutz et al http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Cancer Biology Schmutz, Isabelle Mensenkamp, Arjen R Takai, Kaori K Haadsma, Maaike Spruijt, Liesbeth de Voer, Richarda M Choo, Seunga Sara Lorbeer, Franziska K van Grinsven, Emma J Hockemeyer, Dirk Jongmans, Marjolijn CJ de Lange, Titia TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title | TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title_full | TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title_fullStr | TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title_full_unstemmed | TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title_short | TINF2 is a haploinsufficient tumor suppressor that limits telomere length |
title_sort | tinf2 is a haploinsufficient tumor suppressor that limits telomere length |
topic | Cancer Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707837/ https://www.ncbi.nlm.nih.gov/pubmed/33258446 http://dx.doi.org/10.7554/eLife.61235 |
work_keys_str_mv | AT schmutzisabelle tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT mensenkamparjenr tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT takaikaorik tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT haadsmamaaike tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT spruijtliesbeth tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT devoerrichardam tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT chooseungasara tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT lorbeerfranziskak tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT vangrinsvenemmaj tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT hockemeyerdirk tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT jongmansmarjolijncj tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength AT delangetitia tinf2isahaploinsufficienttumorsuppressorthatlimitstelomerelength |